Zhao et al. summarized several inhibitors targeting different enzymes in the lipid metabolism network (e.g., ACC, fatty acid synthase, sterol regulatory element-binding protein 1, and stearoyl-CoA desaturase) and discussed targeting lipid metabolism in ovarian cancer[104]. Here, SCD is linked to ovarian cancer.